[Award Report] FY2022 Takemi Memorial Award for Research in Seizon and Life Sciences (The Takemi Memorial Award for Research in Seizon and Life Sciences, December 2022)
date : 3/3/2023
Tags: Other activities
![[Award Report] FY2022 Takemi Memorial Award for Research in Seizon and Life Sciences (The Takemi Memorial Award for Research in Seizon and Life Sciences, December 2022)](https://hgpi.org/en/wp-content/uploads/sites/2/lecture-media-213-top.png)
Health and Global Policy Institute (HGPI) Board Member and CEO Mr. Ryoji Noritake has been awarded the FY2022 Takemi Memorial Award for Research in Seizon and Life Sciences. Mr. Noritake was recognized for his contributions to the development of a mature civil society by creating opportunities for diverse stakeholders in society and the parties most affected in various areas to come together for exchanges of opinion that surpass the positions of individuals. At Mr. Noritake’s request, the monetary prize from the award has been donated to HGPI.
■ Introducing the Takemi Memorial Award for Research in Seizon and Life Sciences
The Takemi Memorial Award for Research in Seizon and Life Sciences recognizes individuals or groups who will serve as future leaders of Japan and have made noteworthy achievements through innovative research and practical activities in basic, clinical, and social medicine in life sciences or related fields. (From the website of the Takemi Memorial Award for Research in Seizon and Life Sciences.)
For further details, please refer to the website of the Takemi Memorial Award for Research in Seizon and Life Sciences.
Top Research & Recommendations Posts
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Publication Report] Planetary Health Promotion Project “Issues Facing Planetary Health and the Role of the Health Sector” (May 10, 2023)
- [Announcement] HGPI Endorses the “Belém Health Action Plan” (November 14, 2025)
Featured Posts
-
2026-01-09
[Registration Open] (Hybrid Format) Dementia Project FY2025 Initiative Concluding Symposium “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (March 9, 2026)
![[Registration Open] (Hybrid Format) Dementia Project FY2025 Initiative Concluding Symposium “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (March 9, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/dementia-20260309-top.png)
-
2026-01-22
[Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)
![[Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/is-20260122-top_ENG.png)
-
2026-01-26
[HGPI Policy Column] (No.68) – From the Intractable and Rare Diseases Project “Part 2 – Making Intractable and Rare Diseases a Priority Issue for the International Community: The WHA Resolution’s Vision for a Global Action Plan and Japan’s Role”
![[HGPI Policy Column] (No.68) – From the Intractable and Rare Diseases Project “Part 2 – Making Intractable and Rare Diseases a Priority Issue for the International Community: The WHA Resolution’s Vision for a Global Action Plan and Japan’s Role”](https://hgpi.org/en/wp-content/uploads/sites/2/Eyecatch_Column_RD_2-1.png)
-
2026-01-26
[Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
![[Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)](https://hgpi.org/en/wp-content/uploads/sites/2/vc-20250425-top.jpg)
